Your browser doesn't support javascript.
loading
Ubiquitination of MHC Class II Is Required for Development of Regulatory but Not Conventional CD4+ T Cells.
Liu, Haiyin; Wilson, Kayla R; Schriek, Patrick; Macri, Christophe; Blum, Annabelle B; Francis, Lauren; Heinlein, Melanie; Nataraja, Champa; Harris, James; Jones, Sarah A; Gray, Daniel H D; Villadangos, Jose A; Mintern, Justine D.
Affiliation
  • Liu H; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Wilson KR; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Schriek P; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Macri C; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Blum AB; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Francis L; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria 3010, Australia.
  • Heinlein M; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
  • Nataraja C; Department of Medical Biology, The University of Melbourne, Parkville, Victoria 3013, Australia.
  • Harris J; Rheumatology Group, Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria 3168, Australia; and.
  • Jones SA; Rheumatology Group, Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria 3168, Australia; and.
  • Gray DHD; Rheumatology Group, Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria 3168, Australia; and.
  • Villadangos JA; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
  • Mintern JD; Department of Medical Biology, The University of Melbourne, Parkville, Victoria 3013, Australia.
J Immunol ; 205(5): 1207-1216, 2020 09 01.
Article in En | MEDLINE | ID: mdl-32747505
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Histocompatibility Antigens Class II / T-Lymphocytes, Regulatory / Ubiquitination Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Immunol Year: 2020 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Histocompatibility Antigens Class II / T-Lymphocytes, Regulatory / Ubiquitination Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Immunol Year: 2020 Document type: Article Affiliation country: